Showing 9,713 results

Filters Content type: News, Editors' picks, About HIV Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

Injectable & long-acting HIV treatment

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir

Editor's pick
FiercePharma
26 December 2021
Injectable & long-acting PrEP

GlaxoSmithKline's HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it?

Editor's pick
FiercePharma
26 December 2021
Improving HIV care

Deaf People Aging With HIV Face Communication Barriers

Editor's pick
POZ
21 December 2021
New & experimental HIV treatments

Trials of long-acting islatravir for HIV treatment and prevention placed on hold

News
21 December 2021
TB transmission & prevention

South Africa: What is government doing to restore TB services?

Editor's pick
Spotlight
20 December 2021
Improving HIV care

Queer men and trans women in Kenya prefer services run by community members over state-run and private clinics

News
20 December 2021
PrEP policies & guidelines

UK: NICE recommends offering PrEP to people at high risk of HIV for first time

Editor's pick
National Institute for Health and Care Excellence (NICE)
17 December 2021
Improving HIV care

Uganda tests drones to speed up delivery of HIV medicine

Editor's pick
Reuters
17 December 2021
Reproductive health

Reproductive rights and the bigger picture for Roma women

News
17 December 2021
News about aidsmap

Thank you!

News
14 December 2021
Improving HIV care

All Together Now: Needle Exchange and HIV Telehealth in Miami

Editor's pick
POZ
14 December 2021
Injectable & long-acting HIV treatment

Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection

Editor's pick
Merck press release
14 December 2021
Transgender people

HIV prevention must be ‘tailored to the needs of trans individuals’

Editor's pick
Medical News Today
13 December 2021
Global health targets

Study Finds Slower Viral Suppression Progress in Children, Adolescents Than Adults With HIV

Editor's pick
American Journal of Managed Care
13 December 2021
Retention & linkage to care

Many effective interventions that improve HIV outcomes for Black men who have sex with men exist – now they need to be scaled up

News
13 December 2021
Economic & social inequality

WHO and Global Fund Warn Inequalities Block Progress Towards Ending AIDS, TB and Malaria

Editor's pick
The Global Fund to Fight AIDS, Tuberculosis and Malaria
9 December 2021
Pharmaceutical industry

'Pharma Bro' firm reaches $40M settlement in gouging case

Editor's pick
Associated Press
9 December 2021
Injectable & long-acting HIV treatment

Long-Acting HIV Therapy Hits a Snag

Editor's pick
POZ
9 December 2021
Finance & funding

HIV Prevention R&D Funding Drops Again, Even as Major Scientific Advances Require Support

Editor's pick
AVAC
9 December 2021
Injectable & long-acting HIV treatment

The Medicines Patent Pool and the University of Washington sign a licence agreement for an investigational long-acting injectable drug combination candidate for HIV

Editor's pick
Medicines Patent Pool
9 December 2021
PrEP programmes & uptake

Practitioners and policies create barriers to PrEP and HIV testing for young people in sub-Saharan Africa

News
8 December 2021
Drug policy & policing

English government announces ‘largest ever’ increase in drug treatment funding

Editor's pick
Drink and Drugs News
7 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021